Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer

The treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced non-small-cell lung cancer (NSCLC) is challenging because there is no randomized controlled trial has been reported. The value of neoadjuvant and adjuvant targeted therapy remains unclear. Herein, we show that systemic treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Xie, Xiao-Hong, Zhan, Ze-Jiang, Qin, Yin-Yin, Jiang, Ju-Hong, Yin, Wei-Qiang, Zheng, Rong-Hui, Li, Shi-Yue, Zhou, Cheng-Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010235/
https://ncbi.nlm.nih.gov/pubmed/33816312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.655856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados